- Previous Close
22.80 - Open
22.80 - Bid 21.80 x --
- Ask 23.10 x --
- Day's Range
22.80 - 23.60 - 52 Week Range
16.90 - 45.00 - Volume
18,476 - Avg. Volume
98,636 - Market Cap (intraday)
24.377M - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.10 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and sports pain, orthopedics, and others; and B-Cure Laser Sport Pro, a professional device for treating sports injuries, and pain relief in areas of the body and muscles, as well as infections, including Achilles tendonitis. In addition, it offers B-Cure Laser Dental, a device for use in dental clinics to treat dental problems, relieve gum pain, and inflammation, as well as helps in the recovery process after dental treatment, including implants, and in reducing pain and swelling; and B-Pro Dental Laser Cure, a device for the treatment of dental problems and infections in dental clinics. The company was formerly known as Erica Carmel Ltd and changed its name to Erika B-Cure Laser Ltd in January 2022. Erika B-Cure Laser Ltd was incorporated in 2007 and is headquartered in Haifa, Israel.
bcurelaser.comRecent News: BCUR.TA
View MorePerformance Overview: BCUR.TA
Trailing total returns as of 12/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BCUR.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BCUR.TA
View MoreValuation Measures
Market Cap
23.75M
Enterprise Value
19.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.58
Price/Book (mrq)
0.98
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-29.97%
Return on Assets (ttm)
-13.18%
Return on Equity (ttm)
-34.48%
Revenue (ttm)
32.88M
Net Income Avi to Common (ttm)
-9.85M
Diluted EPS (ttm)
-0.10
Balance Sheet and Cash Flow
Total Cash (mrq)
7.7M
Total Debt/Equity (mrq)
15.24%
Levered Free Cash Flow (ttm)
-370.38k